Less is more: thousands skip unnecessary cancer scans in landmark study
NCT ID NCT06803147
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows over 3,000 people with low-risk Barrett's esophagus who have stopped having routine endoscopic surveillance, as recommended by new guidelines. Researchers will track them for at least 10 years to see if stopping these scopes leads to a rise in serious esophageal cancer cases. The goal is to confirm that skipping unnecessary procedures is safe and reduces patient burden.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antoni van Leeuwenhoek - Centrum voor Vroegdiagnostiek (Barrett Coordination Centre)
RECRUITINGAmsterdam, 1066 CX, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which biopsy method best spots early esophageal cancer?
- New cutting tool may outperform heat therapy for Barrett's esophagus
- Scarless procedure may keep precancerous esophagus changes from returning
- Glowing dye could reveal invisible cancer clues in the esophagus
- Freezing out cancer risk: new balloon treatment for Barrett's esophagus
- Spit test may spot reflux risk after gastric sleeve surgery